Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mangoceuticals, Inc. - Common Stock (NQ: MGRX )

2.500 +0.030 (+1.21%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mangoceuticals, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter
Via Benzinga
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Consumer Staples Stocks Moving In Friday's After-Market Session
Via Benzinga
Men's Telehealth Company's Plans To Change Men's Wellness
Men's Telehealth Company's Plans To Change Men's Wellness 
Via News Direct
MGRX Stock Earnings: Mangoceuticals Reported Results for Q2 2024
Mangoceuticals just reported results for the second quarter of 2024. 
Via InvestorPlace
11 Consumer Staples Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Consumer Staples Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Consumer Staples Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform
Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform 
Via News Direct
Exposures COVID-19
MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market
Via ACCESSWIRE
Why Is Mangoceuticals (MGRX) Stock Up 130% Today?
MGRX stock is up today after the company announced promising clinical trial results for its oral weight-loss drugs. 
Via InvestorPlace
MGRX Stock Earnings: Mangoceuticals Reported Results for Q1 2024
Mangoceuticals just reported results for the first quarter of 2024. 
Via InvestorPlace
This Men’s Telehealth Company Has A Unique Take On Telehealth And Products
This Men’s Telehealth Company Has A Unique Take On Telehealth And Products 
Via News Direct
Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future
Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future 
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
Erectile Function Vs Erectile Dysfunction: How MangoRx’s (NASDAQ: MGRX) Product Sets Itself Apart and Caters to a Large Market (Pun Intended)
Erectile Function Vs Erectile Dysfunction: How MangoRx’s (NASDAQ: MGRX) Product Sets Itself Apart and Caters to a Large Market (Pun Intended) 
Via News Direct
Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend! 
Via InvestorPlace
MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts
Via ACCESSWIRE
12 Consumer Staples Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Urban Outfitters Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Consumer Staples Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out on Wednesday as we offer up all the latest news sending shares higher and lower this morning! 
Via InvestorPlace
Gold Moves Lower; Macy's Boosts 2024 Forecast
Via Benzinga
Crude Oil Moves Lower; Lowe's Earnings Top Views
Via Benzinga
Exposures Fossil Fuels
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Mangoceuticals Develops Oral GLP-1s: Stock Soars
Mangoceuticals announced the development of proprietary oral formulations of Semaglutide ("Slim") and Tirzepatide ("Trim") to aid in weight management and said it plans to have the products available... 
Via Benzinga
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter results. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.